News & Updates
Filter by Specialty:
Which factors predict sustained seizure reduction with brivaracetam in focal epilepsy?
In patients with focal epilepsy, seizure frequency at baseline and the number of previous antiseizure medications (ASMs) used can predict sustained reduction in seizure frequency with adjunctive brivaracetam, according to data from the BRIVAFIRST study.
Which factors predict sustained seizure reduction with brivaracetam in focal epilepsy?
22 Aug 2023
Does concomitant TKI‒SSRI use increase risk of bleeding, thrombotic events?
Patients with chronic myeloid leukaemia (CML) who are being treated with both tyrosine kinase inhibitors (TKIs) and selective serotonin reuptake inhibitors (SSRIs) do not appear to be at greater total risk of bleeding or thrombotic events than those on TKIs only, reveals a study. However, concomitant use of TKIs and SSRIs may elevate the risk of intracranial bleeding.
Does concomitant TKI‒SSRI use increase risk of bleeding, thrombotic events?
19 Aug 2023
Fezolinetant reduces menopause-related vasomotor symptoms
Treatment with fezolinetant 30 and 45 mg daily provides relief from moderate-to-severe vasomotor symptoms (VSM) associated with menopause, suggests a study.
Fezolinetant reduces menopause-related vasomotor symptoms
18 Aug 2023
Long-term hydrochlorothiazide use ups risk of skin cancer
Using hydrochlorothiazide (HCTZ) for longer durations and in higher cumulative doses increases the risks for keratinocyte carcinoma and melanoma, reveals a study.